Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms

Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms

Abstract Background Treatment with erythropoietin (Epo) in experimental autoimmune encephalomyelitis (EAE), the rodent model of multiple sclerosis (MS), has consistently been shown to ameliorate disease progression and improve overall outcome. The effect has been attributed to modulation of the immu...

Full description

Bibliographic Details
Main Authors: M. Moransard, M. Bednar, K. Frei, M. Gassmann, O. O. Ogunshola
Format: Article
Language:English
Published: BMC 2017-10-01
Series:Journal of Neuroinflammation
Subjects:
Multiple sclerosis
Myelin
Immunomodulation
Epo
EAE
Experimental autoimmune encephalomyelitis
Online Access:http://link.springer.com/article/10.1186/s12974-017-0976-5

Internet

http://link.springer.com/article/10.1186/s12974-017-0976-5

Similar Items